Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancerCharles Lu, Ritsuko Komaki, Jin Soo Lee, et al.
American Journal of Clinical Oncology|November 1, 2012
Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer before chemoradiation therapyDaniel R Gomez, Gregory W Gladish, Xiong Wei, et al.
JCO Oncology Practice|February 23, 2023
Integration of Remote Symptom and Biometric Monitoring Into the Care of Adult Patients With Cancer Receiving Chemotherapy-A Decentralized Feasibility Pilot StudyAnaeze C Offodile, Domenica Delgado, Yu-Li Lin, et al.
Cancer|March 13, 2010
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancerWilliam N William, Merrill S Kies, Frank V Fossella, et al.
Clinical Lung Cancer|November 5, 2003
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancerFaye M Johnson, Jonathan M Kurie, Beverly O Peeples, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resectionNoah A Taylor, Zhongxing X Liao, James D Cox, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancerGustavo Schvartsman, S Andrew Peng, Giorgios Bis, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2017
Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 StudyMelenda D Jeter, Daniel Gomez, Quynh-Nhu Nguyen, et al.
Cancer Chemotherapy and Pharmacology|June 9, 2004
Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumorsHai T Tran, George R Blumenschein, Charles Lu, et al.
Cancer|May 2, 2023
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancerMehmet Altan, Janet Tu, Denái R Milton, et al.
Pageof 7